On the 20th anniversary of the U.S. Food and Drug Administration’s approval of growth hormone (GH) treatment for idiopathic short stature (ISS), Adda Grimberg, MD, and Colin P. Hawkes, MD, PhD, both of the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, published a mini-review in The Journal...
A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis with the use of prescribed testosterone. However, Mount Sinai researchers have found that testosterone treatment may be safer than previously reported, with results published recently in The Journal of Clinical Endocrinology & Metabolism. Mount...
Getting Back to Normal: Options for Treating Hypoparathyroidism
Endocrine News talks to Aliya Khan, MD, about the debilitating effects of hypoparathyroidism, new treatment guidelines she helped create, and exciting news from trials that showed promising results that could allow these patients to have a much-improved quality of life, both physical and psychological. “I wish I had this medicine when I was a kid,”...
Demand for testosterone therapy has soared in the United States with more men seeking to increase hormone levels in hopes of enhancing virility, strength and energy. Testosterone therapy has become a burgeoning business with direct-to-consumer men’s health platforms proliferating online in recent years. While testosterone therapy benefits some men, it can be harmful for others,...
A paper recently published in Endocrine Reviews looks to provide readers with an improved understanding in approaches to using hormone therapy to treat menopausal women. The review, by Valerie Flores, MD, and Lubna Pal, MD, of Yale School of Medicine and JoAnn Manson, MD, of Harvard Medical School, points out that hormone therapy remains the...
CEU 2021 Preview: Does Testosterone Therapy Have a Place in Treating Women?
At the all-virtual CEU 2021 in September, two contributors to a global consensus statement, Susan R. Davis, MBBS, FRACP, and Margaret E. Wierman, MD, will describe the use — and misuse — of giving women testosterone. This upcoming Clinical Endocrinology Update session sounds as if it could feature lively disagreement: “Endocrine Debate: Testosterone Therapy...Gut Instincts: The Endocrinologists Behind the 2020 Warren Alpert Foundation Prize
Endocrine Society members Daniel J. Drucker, MD, and Joel F. Habener, MA, MD, talk to Endocrine News about their 2020 Warren Alpert Foundation Prize-winning research of key intestinal hormones, as well as their distinguished careers and what this award means to them. On October 1, the Warren Alpert Foundation Prize will be presented in a...
Individuals Taking Class of Steroid Medications at High Risk for COVID-19
JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according...
